Professional Documents
Culture Documents
Revenue
(YOY change %) 6.92 8.56
Revenue
(5 yr growth rate) 14.28 1.81
Net income
(YOY change %) 14.01 -11.59
Net income
(5 yr growth rate) 23.34 4.61
Capital expenditure
(5 yr growth rate) -8.5 7.68
Dividend
(5 yr growth rate) 12.47 2.96
Profitability Chugai, Astellas, Takeda, and Otsuka are generating high levels of g
Moreover, Shionogi and Chugai have been consistently profitable o
Gross margin 37.4 70.7
Gross margin
(5 yr avg) 44.12 64.23
Net profit margin 1.61 5.02
Net Profit margin
(5 yr avg) 10.22 8.66
Takeda Pharmaceutical Otsuka Holdings Co Ltd Eisai Co., Ltd. Astellas Pharma Inc
Co Ltd (4502:TYO) (4578:TYO) (4523:TYO) (4503:TYO)
0 0 1.3 8.02
uka are generating high levels of gross and net profit margins, while Towa has relatively lower profitability compared to the ot
ave been consistently profitable over the past five years.
68.5 67.23 74.22 80.59
5.69k 7.77k
1919 1943
Astellas stands out with a high net profit margin, and
453.86bn 1.26tn
200.91bn 374.43bn
1.88tn 5.73tn
Chugai has the highest P/B, indicating that investors
pay a premium for its book value. Finally, Eisai has the
pany.
9.06 15.01
1.7 3.94
8.62 --
4.13 4.55
ry the best, while Astellas has the highest revenues per
0.3946 0.7393
1.2 1.9
3.71 2.9
79,722,110.00 162,134,400.00
chi are generating lower returns on their assets and
17.43 21.97
13.39 18.69
19.85 28.18
15.07 23.03
is focused on increasing shareholder returns through
nogi are investing in capital expenditure to support
12.77 26.02
-0.2224 18.72
2.08 23.58
6.36 38.79
6.3 9.86
9.82 30.43
ower profitability compared to the other companies.
86.75 62.2
82.47 62.55
44.17 29.72
35.36 26.5